Back to top
more

Avinger (AVGR)

(Real Time Quote from BATS)

$1.69 USD

1.69
11,513

-0.07 (-3.98%)

Updated Jul 22, 2024 01:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (143 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Air Methods (AIRM) Set to be Acquired for $2.5 Billion

by Zacks Equity Research

Air Methods Corporation (AIRM) announced that it is set to be acquired by New York-based private equity firm American Securities LLC for $2.5 billion.

    AngioDynamics Microwave Tissue Ablation System Now CE Marked

    by Zacks Equity Research

    AngioDynamics Inc. (ANGO), a leading provider of minimally invasive medical devices, recently announced the receipt of CE mark for Solero Microwave Tissue Ablation (MTA) System.

      Stryker Launches MAKO Robotic-Arm for Knee Anthroplasty

      by Zacks Equity Research

      Stryker Corporation (SYK) recently announced the commercial launch of a robotic-arm assisted total knee arthroplasty application based on its flagship MAKO System.

        Ensign Group Signs Lease Agreement with Mainstreet Health

        by Zacks Equity Research

        The Ensign Group, Inc. (ENSG) recently signed definitive agreements to simultaneously sell and lease two skilled nursing facilities and one assisted living community to Mainstreet Health Investments Inc.

          Is it Wise to Hold Universal Health (UHS) in Your Portfolio?

          by Zacks Equity Research

          Headquartered in King of Prussia, PA, Universal Health Services Inc. (UHS) stock has gained 12.8% year to date, significantly higher than the increase of 7.6% witnessed by the Zacks categorized medical sector.

            Tenet Healthcare (THC) Signs Multi-Year Deal with BCBSTX

            by Zacks Equity Research

            Tenet Healthcare Corporation (THC) recently inked a deal with Blue Cross and Blue Shield of Texas ("BCBSTX").

              Cantel Medical (CMD) Q2 Earnings & Sales Grow Year Over Year

              by Zacks Equity Research

              Cantel Medical Corp. (CMD) reported adjusted earnings of 52 cents per share in the second quarter of fiscal 2017.

                ABIOMED Impella Heart Pump Reduces Kidney Injury during PCI

                by Zacks Equity Research

                A new study demonstrates that ABIOMED's flagship Impella 2.5 heart pump can reduce the risk of acute kidney injury during high-risk percutaneous coronary intervention (PCI).

                  Humana's Subsidiaries Receive Rating Action from A.M. Best

                  by Zacks Equity Research

                  Humana Inc. (HUM) recently received rating action from A.M. Best. The rating giant has removed from under review, with positive implications, the majority of insurance subsidiaries of the company.

                    UnitedHealth's Senior Unsecured Notes Rated by A.M Best

                    by Zacks Equity Research

                    UnitedHealth Group, Inc.'s (UNH) senior unsecured notes recently received rating action from A.M Best.

                      Cooper Companies (COO) Receives ISO 15189 Accreditation

                      by Zacks Equity Research

                      The Cooper Companies Inc. (COO) announced that its London and Nottingham-based laboratories received the International Organization for Standardization 15189 accreditation.

                        C. R. Bard (BCR) Well Poised for Growth, Macro Woes Remain

                        by Zacks Equity Research

                        We issued an updated research report on C. R. Bard Inc. (BCR) on Mar 8, 2017.

                          UnitedHealth's (UNH) Senior Unsecured Debt Rated by Moody's

                          by Zacks Equity Research

                          UnitedHealth Group Inc. (UNH) recently announced that its senior unsecured debt has been assigned an A3 rating by Moody's Investors Service, a wing of Moody???s Corporation (MCO).

                            Baxter (BAX) Hits a 52-Week High: What's Driving the Stock?

                            by Zacks Equity Research

                            Share price of Baxter International Inc. (BAX), a global medical technology company, rallied to a new 52-week high of $51.43 on Mar 8, eventually closing a bit lower at $51.36.

                              Intersect ENT: FDA Submission of RESOLVE Implant, Stock Up

                              by Zacks Equity Research

                              Intersect ENT, Inc (XENT) recently announced the submission of a New Drug Application (NDA) approval with the U.S. FDA for reviewing its investigational RESOLVE steroid releasing implant.

                                OPKO Health (OPK) Launches Prenatal Testing Tool ClariTest

                                by Zacks Equity Research

                                OPKO Health Inc. (OPK) recently announced the launch of a non-invasive medical test to detect fetal abnormalities.

                                  Community Health Prices Senior Secured Notes Worth $2.2B

                                  by Zacks Equity Research

                                  Community Health Systems, Inc. (CYH) recently announced that it has issued 6.25%, $2.2 billion Senior Secured Notes, due 2023. The offering was upsized by $450 million.

                                    Meridian (VIVO) to Provide LeadCare Testing System in Africa

                                    by Zacks Equity Research

                                    Meridian Bioscience, Inc. (VIVO), a renowned life sciences company, recently signed an exclusive distribution agreement with Biofirm Technologies.

                                      TransEnterix (TRXC) Reports Wider-Than-Expected Loss in Q4

                                      by Zacks Equity Research

                                      TransEnterix, Inc. (TRXC) reported a loss of 12 cents per share in the fourth quarter of 2016, wider than the Zacks Consensus Estimate of a loss of 11 cents.

                                        Masimo Announces Availability of RD SedLine Brain Sensors

                                        by Zacks Equity Research

                                        Masimo Corporation (MASI) recently announced the availability of the RD SedLine EEG sensor, which can be used with the company???s flagship SedLine Brain Function Monitoring technology.

                                          Allscripts (MDRX) Acknowledged by LPP's CDIS Framework

                                          by Zacks Equity Research

                                          Allscripts Healthcare Solutions, Inc. (MDRX) recently announced that it has been accepted and acknowledged by the NHS London Procurement Partnership (LPP) in its Clinical and Digital Information Systems (CDIS) Framework.

                                            DexCom (DXCM) Incurs Narrower Loss in Q4, Beats on Revenues

                                            by Zacks Equity Research

                                            DexCom Inc. (DXCM) reported loss of nine cents per share in the fourth quarter of 2016, narrower than the Zacks Consensus Estimate of a loss of 10 cents.

                                              The Cooper Companies (COO) Beats Earnings Estimates in Q1

                                              by Zacks Equity Research

                                              The Cooper Companies Inc.(COO) reported adjusted earnings of $1.93 in first-quarter fiscal 2017, surpassing the Zacks Consensus Estimate by 7 cents and improving 5.5% on a year-over-year basis.

                                                NxStage Medical: NxGen Hemodialysis System Now CE Marked

                                                by Zacks Equity Research

                                                NxStage Medical, Inc. (NXTM) recently announced the receipt of CE mark for its NxGen Hemodialysis System, an innovative device with easier user interface and integrated blood pressure monitor system for patients performing home hemodialysis.

                                                  5 Stocks with Rising P/E to Enjoy Stellar Gains

                                                  by Zacks Equity Research

                                                  Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.